Fiche centre
Amsterdam UMC
Amsterdam — Netherlands
Essais liés7clinical trials
VilleAmsterdamlocalisation
PaysNetherlandslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05374291
Essais cliniques associés
7| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Selatogrel | Maladie coronarienne | Phase 3 | NCT04957719 | SOS-AMI — Selatogrel Outcome Study in Suspected Acute Myocardial Infarction | ENROLLING_BY_INVITATION |
| Focal Therapy | Cancer | Non applicable | NCT06223295 | ENFORCE — Effectiveness of Focal Therapy in Men With Prostate Cancer | RECRUITING |
| Stereotactic body radiotherapy | Cancer | Non applicable | NCT04081168 | COLLISION-XL — COLLISION XL: Unresectable Colorectal Liver Metastases (3-5cm): Stereotactic Body Radiotherapy vs. Microwave Ablation | UNKNOWN |
| Dapagliflozin 10 mg/day (oral) | Maladie rénale chronique | Phase 3 | NCT05374291 | The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD | ACTIVE_NOT_RECRUITING |
| Optimized conventional DBS | Parkinson | Non applicable | NCT07105280 | CTRL-PD — Closed-Loop Therapeutic Refinement Using Local Field Potentials in Parkinson's Disease | NOT_YET_RECRUITING |
| [18F]ACI-19626 PET in TDP-43 Proteinopathies | Sclérose latérale amyotrophique | Phase 1 | NCT06891716 | [18F]ACI-19626 PET in TDP-43 Proteinopathies | RECRUITING |
| TIME-NL — Timing of Immunotherapy in Melanoma | Cancer | Non applicable | NCT07696715 | TIME-NL — Timing of Immunotherapy in Melanoma | RECRUITING |